维普中文期刊产品整合服务
104篇 您的检索式:作者名="Hurria"
    题名 作者 年代 出处 被引量
1Management of lung cancer in elder adults显示文摘Hurria A Kris MG 2003CA Cancer J Clin2003,53,6:1
2Renaming 'Chemobrain' 显示文摘Hurria A Somlo G Ahles T 2007Cancer Invest2007,25,:1
3Management of lung cancer in older adults显示文摘Hurria A K ris MG 0,,:1
4Future of cancer incidence in the United States:burdens upon an aging,changing nation显示文摘Smith BD Smith GL Hurria A 0,,:1
5Predicting chemotherapy tox- icity in older adults with cancer: a prospective multicenter study 显示文摘Hurria A TK Mohile SG Owusu C 2011J Clin Oncol2011,29,:1
6Predicting chemotherapy toxicity in older adults with cancer: a prospective multieenter study显示文摘Hurria A Togawa K Mohile SG 2011J Clin Oncol2011,29,:1
7Management of elderly patients with cancer 显示文摘HURRIA A 2013J Natl Compr Cane Netw2013,11,5:1
8Comprehensive geriatric assessment for older patients with cancer显示文摘Extermann M Hurria A 2007J Clin Oncol2007,25,:1
9Management of lung cancer in older adults 显示文摘Hurria A Kfis MG 2003CA Cancer J Clin2003,53,6:1
10Survivorship education for Latina breast cancer survivors: Empowering Survivors through education 显示文摘Juarez G Mayorga L Hurria A 2013Psicooncologia (Pozuelo de Alarcon)2013,10,1:1
11Postmastectomy radiation and survival in older women with breast cancer显示文摘Smith BD Haffty BG Hurria A 2006J Clin Oncol2006,24,30:1
12Under-representation of older adults in cancer registration trials:known problem,little progress显示文摘Scher KS Hurria A 2012J Clin Oncol2012,30,17:1
13早期乳腺癌最佳辅助化疗方案与人类表皮生长因子受体2阳性乳腺癌辅助靶向治疗选择:依据 ASCO 对 CCO临床实践指南的改编显示文摘目的研究加拿大安大略癌症治疗中心(CCO)关于早期乳腺癌最佳辅助化疗方案,包括人类表皮生长因子受体2(HER2)阳性乳腺癌辅助靶向治疗方案,并对其进行改编。方法按照美国临床肿瘤协会(ASCO)对其他组织临床实践指南改编的策略和程序,对CCO临床实践指南的严谨性与内容适用性进行回顾。结果基于对CCO临床实践指南内容的回顾,ASCO小组认为,CCO临床实践指南在整体上清晰全面,以最确切的科学证据为基础,为患者提供可接受的治疗选项。推荐关于辅助化疗方案的决定,应考虑到基线复发风险、毒性、利益可能性和宿主因素(如合并症)。对于高风险HER2阴性的身体状况良好的人群,蒽环类和紫杉烷治疗方案是标准治疗方案。4个周期的多西他赛和环磷酰胺治疗方案是可接受的非蒽环类治疗方案。对于高风险HER2阳性患者,推荐蒽环类与紫杉烷序贯疗法联合曲妥单抗或多西他赛、卡铂、曲妥单抗进行6个周期的治疗。对于低风险、非淋巴结转移、HER2阳性人群,推荐每周一次的紫杉醇和曲妥单抗连续进行12个周期的替代治疗。曲妥单抗应持续使用1年。不应采用铂复合盐对三阴性人群进行常规的辅助管理,除非出现有效的生存数据加以支持。Neelima Denduluri Mark R Somerfield Andrea Eisen Jamie N Holloway Arti Hurria Tari A King Gary H Lyman Ann H Partridge Melinda L Telli Maureen E Trudeau Antonio C Wolff 本刊编辑部 2016中国全科医学2016,19,18:1
14Management of lung cancer in older adults显示文摘Hurria A Kris MG 2003CA Cancer J Clin2003,53,:1
15Future of cancer inci- dence in the United States:Burdens upon an aging, changing nation显示文摘Smith B D Smith G L Hurria A 2009J Clin Oncol2009,27,17:1
16Management of lung cancer in older adults 显示文摘Hurria A Kris MG 2003CA Cancer J Clin2003,53,6:1
17Developing a can- cer- specific geriatric assessment: a feasibility study显示文摘Hurria A Gupta S Zauderer M 2005Cancer2005,104,9:1
18Management of lung cancer in older adults显示文摘Hurria A Kris MG 2003CA Cancer J Clin2003,53,:1
19Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer显示文摘Chen J Long JB Hurria A 2012J Am Coil Cardiol2012,60,24:1
20Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer:assessing outcome in a population-based,observational cohort显示文摘ELKIN E B HURRIA A MITRA N 2006Clin Oncol2006,24,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费